Strategies to Make Telemedicine a Friend, Not a Foe, in the Provision of Accessible and Equitable Cancer Care

Telemedicine has the potential to improve access to cancer care, particularly for patients with functional limitations, high symptom burdens, or financial or geographic constraints. However, there is also a risk that telemedicine can widen healthcare disparities among patients facing systemic disadv...

Full description

Saved in:
Bibliographic Details
Published inCancers Vol. 15; no. 21; p. 5121
Main Authors Calton, Brook A, Nouri, Sarah, Davila, Carine, Kotwal, Ashwin, Zapata, Carly, Bischoff, Kara E
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 24.10.2023
Subjects
access
barriers
Cancer
Cancer patients
COVID-19
disparities
equity
Health care
Health care disparities
Information literacy
Interpreters
Smartphones
Socioeconomic factors
telehealth
Telemedicine
Training
California
United States > US
disparities
telemedicine
access
barriers
equity
telehealth
Online AccessGet full text

Cover

More Information
Summary:Telemedicine has the potential to improve access to cancer care, particularly for patients with functional limitations, high symptom burdens, or financial or geographic constraints. However, there is also a risk that telemedicine can widen healthcare disparities among patients facing systemic disadvantages like those with technological barriers, poor digital literacy, older age, or non-English language preferences. To optimize telemedicine usage, we must implement practical strategies like video onboarding programs, user-friendly technology platforms, optimizing the clinician's environment, and best practices for using interpreters. Policy changes such as state licensing requirements, controlled substance prescribing requirements, and payment parity are also crucial. This Perspective highlights these practical strategies and policy recommendations to ensure accessible and equitable cancer care augmented by telemedicine.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers15215121